BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 27530398)

  • 1. Current Status and Future of Skin Substitutes for Chronic Wound Healing.
    Nicholas MN; Yeung J
    J Cutan Med Surg; 2017; 21(1):23-30. PubMed ID: 27530398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Cellular and Acellular Matrix Products: Indications, Techniques, and Outcomes.
    Hughes OB; Rakosi A; Macquhae F; Herskovitz I; Fox JD; Kirsner RS
    Plast Reconstr Surg; 2016 Sep; 138(3 Suppl):138S-147S. PubMed ID: 27556754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Guide to Tissue-Engineered Skin Substitutes.
    Kallis PJ; Friedman AJ; Lev-Tov H
    J Drugs Dermatol; 2018 Jan; 17(1):57-64. PubMed ID: 29320588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of skin substitutes in the management of chronic cutaneous wounds.
    Greaves NS; Iqbal SA; Baguneid M; Bayat A
    Wound Repair Regen; 2013; 21(2):194-210. PubMed ID: 23437811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic wound care: a meta-review of cochrane systematic reviews.
    Ubbink DT; Santema TB; Stoekenbroek RM
    Surg Technol Int; 2014 Mar; 24():99-111. PubMed ID: 24700218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes.
    Spiekstra SW; Breetveld M; Rustemeyer T; Scheper RJ; Gibbs S
    Wound Repair Regen; 2007; 15(5):708-17. PubMed ID: 17971017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US skin disease assessment: ulcer and wound care.
    Markova A; Mostow EN
    Dermatol Clin; 2012 Jan; 30(1):107-11, ix. PubMed ID: 22117872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current challenges in wound care management: an overview.
    Evans C; Hagelstein SM; Ivins N
    Br J Community Nurs; 2000 Jul; 5(7):332, 334-6, 338-9. PubMed ID: 12271221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular therapy and leg ulcers: Future approaches].
    Senet P
    Ann Dermatol Venereol; 2015; 142(8-9):519-22. PubMed ID: 26188963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts.
    Kuroyanagi Y; Yamada N; Yamashita R; Uchinuma E
    Artif Organs; 2001 Mar; 25(3):180-6. PubMed ID: 11284884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regenerative materials that facilitate wound healing.
    Mulder G; Wallin K; Tenenhaus M
    Clin Plast Surg; 2012 Jul; 39(3):249-67. PubMed ID: 22732374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic wound repair and healing in older adults: current status and future research.
    Gould L; Abadir P; Brem H; Carter M; Conner-Kerr T; Davidson J; DiPietro L; Falanga V; Fife C; Gardner S; Grice E; Harmon J; Hazzard WR; High KP; Houghton P; Jacobson N; Kirsner RS; Kovacs EJ; Margolis D; McFarland Horne F; Reed MJ; Sullivan DH; Thom S; Tomic-Canic M; Walston J; Whitney JA; Williams J; Zieman S; Schmader K
    J Am Geriatr Soc; 2015 Mar; 63(3):427-38. PubMed ID: 25753048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin substitutes based on allogenic fibroblasts or keratinocytes for chronic wounds not responding to conventional therapy: a retrospective observational study.
    Pajardi G; Rapisarda V; Somalvico F; Scotti A; Russo GL; Ciancio F; Sgrò A; Nebuloni M; Allevi R; Torre ML; Trabucchi E; Marazzi M
    Int Wound J; 2016 Feb; 13(1):44-52. PubMed ID: 24517418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene array technology and pathogenesis of chronic wounds.
    Tomic-Canic M; Brem H
    Am J Surg; 2004 Jul; 188(1A Suppl):67-72. PubMed ID: 15223505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous full-thickness skin substitute for healing chronic wounds.
    Gibbs S; van den Hoogenband HM; Kirtschig G; Richters CD; Spiekstra SW; Breetveld M; Scheper RJ; de Boer EM
    Br J Dermatol; 2006 Aug; 155(2):267-74. PubMed ID: 16882162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological skin substitutes for wound cover and closure.
    Hrabchak C; Flynn L; Woodhouse KA
    Expert Rev Med Devices; 2006 May; 3(3):373-85. PubMed ID: 16681458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue Engineered Skin Substitutes.
    Goodarzi P; Falahzadeh K; Nematizadeh M; Farazandeh P; Payab M; Larijani B; Tayanloo Beik A; Arjmand B
    Adv Exp Med Biol; 2018; 1107():143-188. PubMed ID: 29855826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Allogeneic Fibroblast Cultured on Acellular Amniotic Membrane for Full-thickness Wound Healing in Rats.
    Mahmoudi Rad M; Talebpour Amiri F; Mirhoseini M; Ghasemi M; Mirzaei M; Mosaffa N
    Wounds; 2016 Jan; 28(1):14-9. PubMed ID: 26779806
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.